Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 7772509 | HLA MATCHED (HLA-MATCHED) | stem cell transplantation | NA | NA | NA | unclassified | |
| on account of the low incidence of gvhd observed following cord blood transplantation, it has been suggested that cord blood be used for hla-matched, or perhaps one or two antigens mismatched, and unrelated stem cell transplantation. | |||||||
| 8832020 | HLA IDENTICAL (HLA-IDENTICAL) | stem cell transplantation | NA | NA | NA | unclassified | |
| we report the second case of gd treated successfully by stem cell transplantation using umbilical cord blood from an hla-identical brother in a 4-year-old girl suffering from severe gd. | |||||||
| 9557210 | HLA MATCHED (HLA-MATCHED) | stem cell transplantation | NA | NA | NA | lack_of_evidence | |
| the patients were cytoreduced with high-dose chemotherapy and autologous stem cell transplantation (asct), and were treated ambulatory with allo-ct consisting of adoptive transfer of hla-matched donor peripheral blood lymphocytes (pbl) activated in vivo with human recombinant interleukin-2 (ril-2). | |||||||
| 9674849 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
| since activation of b7 costimulatory molecules represents an active costimulatory pathway on g-csf-mobilized cd34+ cells, the blockade of these molecules or, alternatively, the use of selected non-immunogenic cd34+/cd18- blood stem cells may represent a new strategy for reducing graft rejection and overcoming hla barriers in allogeneic stem cell transplantation. | |||||||
| 9702091 | HLA IDENTICAL (HLA-IDENTICAL) | cyclophosphamide | NA | melphalan | NA | negation | |
| NA | |||||||
| 9715877 | HLA (HLA) | stem cell transplantation | Dutch | NA | NA | unclassified | |
| stem cell transplantation using cord blood donors mismatched for one or two hla antigens can be successful. | |||||||
| 9827937 | HLA MATCHED (HLA-MATCHED) | cyclophosphamide | NA | fludarabine | NA | positive+negation | |
| NA | |||||||
| 10026673 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
| allogeneic haemopoietic stem cell transplantation is recommended in patients under 50 years with an hla- compatible sibling, with the best outcomes achieved in patients transplanted in first complete remission. | |||||||
| 10101212 | HLA IDENTICAL (HLA-IDENTICAL) | stem cell transplantation | NA | NA | NA | unclassified | |
| most patients may benefit optimally from an allogeneic stem cell transplantation when the transplant is performed as soon as an hla-identical family member has been identified. | |||||||
| 10428273 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
| stable engraftment after megadose blood stem cell transplantation across the hla barrier: the case for natural killer cells as graft-facilitating cells. | |||||||
Copyright 2024